Qingsong Capital
Overview
Qingsong Capital is a private equity investment firm that focuses on the biotechnology and healthcare sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Jiajin Biopharmaceutical (Shanghai) Co., Ltd. | Jun 2026 | Series B++ | Co-investor |
| Gestala | Mar 2026 | Angel | Co-investor |
| Cascade Pharmaceuticals, Inc. | Feb 2026 | VC Round | Co-investor |
| Worg Pharmaceuticals | Dec 2025 | Series D Extension | Co-investor |
| Cornerstone Robotics | Jan 2025 | Series C | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Qingsong Capital based?
Qingsong Capital is headquartered in Beijing, China.
When was Qingsong Capital founded?
Qingsong Capital was founded in 2017.
How many portfolio companies does Qingsong Capital have?
Qingsong Capital has 7 portfolio companies in Caplight's dataset.
What are some companies in Qingsong Capital's portfolio?
Recent investments visible on Caplight include Jiajin Biopharmaceutical (Shanghai) Co., Ltd., Gestala, Cascade Pharmaceuticals, Inc., Worg Pharmaceuticals, Cornerstone Robotics.
What was Qingsong Capital's most recent investment?
Qingsong Capital's most recent investment on Caplight was in Jiajin Biopharmaceutical (Shanghai) Co., Ltd. in 2026.
What sectors does Qingsong Capital focus on?
Qingsong Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does Qingsong Capital focus on?
Qingsong Capital typically invests at the Mid stage.
What is Qingsong Capital's AUM?
Qingsong Capital's assets under management are estimated between $2.2B and $2.2B.